COMP <GO>
HCA vs UNH // REVENUE GROWTH (YOY)
HCA Healthcare Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HCA 11
— UNH 2
▲ REVENUE GROWTH (YOY) LEADER: HCA
LAST: $467.73 (-1.15%) • MKT CAP: $97.71B
revenue-growth
7.10%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCA VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HCA | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.90% | 12.38% | +6.52 | HCA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.5x | 15.3x | -3.77 | HCA | /valuation <GO> |
| Free Cash Flow Yield | 7.43% | 6.25% | +1.18 | HCA | /fcf-yield <GO> |
| Operating Margin | 10.90% | 5.32% | +5.58 | HCA | /operating-margins <GO> |
| Net Profit Margin | 9.00% | 3.53% | +5.47 | HCA | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 7.10% | 3.33% | +3.77 | HCA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.66% | 2.29% | -1.63 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.68 | 3.09 | +0.59 | HCA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | HCA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 55.1 | +1.70 | HCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.33 | +0.71 | HCA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.2x | 17.7x | -3.54 | HCA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $97.71B | $359.43B | -$261.73B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HCA REV | UNH REV | HCA GROSS % | UNH GROSS % | HCA FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $75.60B | $447.57B | — | 88.7% | $7.69B | $16.07B |
| FY 2024 | $70.60B | $400.28B | — | 88.3% | $5.64B | $20.70B |
| FY 2023 | $64.97B | $371.62B | — | 89.6% | $6.51B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCA // BETA 1.04
UNH // BETA 0.33